AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
0.570
+0.011 (1.93%)
At close: Nov 20, 2024, 4:00 PM
0.569
-0.001 (-0.19%)
After-hours: Nov 20, 2024, 4:04 PM EST
AlloVir Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
65.16M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CytomX Therapeutics | 126.62M |
Atara Biotherapeutics | 100.44M |
Metagenomi | 55.08M |
bluebird bio | 53.12M |
Cryo-Cell International | 31.84M |
Cue Biopharma | 9.53M |
InspireMD | 6.82M |
Pheton Holdings | 572.29K |
ALVR News
- 11 days ago - ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR - Business Wire
- 11 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders - GlobeNewsWire
- 13 days ago - AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina - GlobeNewsWire
- 2 months ago - Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm - GlobeNewsWire
- 8 months ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 8 months ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 9 months ago - MARCH 19 FINAL DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 9 months ago - INVESTOR DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire